HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Roberto Manfredi Selected Research

Highly Active Antiretroviral Therapy (HAART)

8/2015[Non-AIDS-associated cancer disorders. A novel scenario after over thirty years from HIV discovery? Clinical experience and literature appraisal].
3/2013Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
12/2009[Malignancies not included among AIDS-defining disorders, in the era of highly active antiretroviral therapy].
7/2008Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.
2/2008HIV infection and the pancreas: risk factors and potential management guidelines.
12/2007Recurring Candida albicans esophagitis in a HIV-infected patient undergoing long-Term antiretroviral therapy, and with absent-negligible immunodeficiency.
12/2006[HIV infection: emerging issues and new challenges].
10/2006Need to evaluate the cost effectiveness of early diagnosis and treatment of osteopenia and osteoporosis in the setting of HIV and highly active antiretroviral therapy.
5/2006Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinations.
1/2006Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administration.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Roberto Manfredi Research Topics

Disease

19Infection
09/2015 - 02/2002
19HIV Infections (HIV Infection)
08/2015 - 12/2002
15Acquired Immunodeficiency Syndrome (AIDS)
04/2015 - 01/2002
7Disease Progression
03/2015 - 12/2004
7Hypertriglyceridemia
02/2014 - 04/2003
6Hypercholesterolemia
01/2014 - 01/2004
5Liver Cirrhosis (Hepatic Cirrhosis)
09/2015 - 01/2006
5Endocarditis
01/2010 - 07/2003
5Lipodystrophy
01/2009 - 01/2004
5Dyslipidemias (Dyslipidemia)
05/2006 - 04/2003
4Insulin Resistance
07/2008 - 01/2004
4Hypersensitivity (Allergy)
04/2008 - 04/2004
4Abscess
05/2007 - 01/2005
3Neoplasms (Cancer)
12/2014 - 09/2003
3Hypertension (High Blood Pressure)
02/2014 - 07/2005
3Atherosclerosis
03/2013 - 01/2004
3Tuberculosis (Tuberculoses)
12/2010 - 01/2006
3Pulmonary Tuberculosis
10/2009 - 01/2006
3Hyperlipidemias (Hyperlipidemia)
09/2009 - 04/2003
3Substance-Related Disorders (Drug Abuse)
09/2008 - 11/2005
3Diabetes Mellitus
07/2008 - 01/2004
3Opportunistic Infections (Opportunistic Infection)
02/2008 - 09/2003
3Hepatitis
06/2007 - 09/2005
3Coronary Artery Disease (Coronary Atherosclerosis)
12/2006 - 01/2004
3Meningitis
04/2006 - 01/2004
2Community-Acquired Infections
09/2015 - 06/2002
2Fatigue
03/2015 - 12/2014
2Exanthema (Rash)
12/2014 - 11/2006
2Wounds and Injuries (Trauma)
01/2014 - 01/2012
2Inflammation
01/2014 - 05/2012
2Bacteremia
01/2010 - 06/2002
2Agranulocytosis (Granulocytopenia)
10/2008 - 12/2007
2Visceral Leishmaniasis (Kala Azar)
06/2008 - 01/2005
2Alcoholism (Alcohol Abuse)
02/2008 - 12/2004
2Fever of Unknown Origin
12/2007 - 02/2006
2Viremia
12/2007 - 03/2003
2Brain Abscess (Abscess, Brain)
05/2007 - 06/2005
2Arthritis (Polyarthritis)
09/2006 - 01/2005
2Cellulitis
09/2006 - 03/2002
2Pancreatic Diseases (Pancreatic Disease)
11/2005 - 12/2004
2Immune Reconstitution Inflammatory Syndrome
07/2004 - 01/2003
2Gynecomastia
04/2004 - 01/2004
2Bacterial Infections (Bacterial Infection)
01/2004 - 06/2002
1Acute Cholecystitis
09/2015

Drug/Important Bio-Agent (IBA)

14Protease Inhibitors (Protease Inhibitor)IBA
02/2014 - 01/2004
10Biological Markers (Surrogate Marker)IBA
03/2015 - 01/2006
8linezolid (Zyvox)FDA Link
01/2010 - 01/2005
6Ritonavir (Norvir)FDA Link
09/2015 - 07/2007
6VancomycinFDA LinkGeneric
01/2010 - 09/2004
5Stavudine (Zerit)FDA LinkGeneric
09/2009 - 12/2004
4tenofovirFDA Link
02/2014 - 05/2006
4Carbon MonoxideIBA
01/2009 - 04/2003
4InterferonsIBA
09/2007 - 01/2006
4TeicoplaninIBA
09/2006 - 07/2003
3MK 0518FDA Link
09/2015 - 12/2014
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2014 - 01/2006
3rosuvastatin (Crestor)FDA Link
01/2014 - 05/2012
3lopinavir (Kaletra)FDA Link
02/2011 - 11/2006
3Ribavirin (Virazole)FDA LinkGeneric
07/2010 - 01/2006
3Pentamidine (NebuPent)FDA LinkGeneric
06/2008 - 12/2004
3liposomal amphotericin BFDA Link
06/2008 - 01/2005
3Didanosine (Videx)FDA LinkGeneric
02/2008 - 12/2004
2efavirenz (Sustiva)FDA Link
09/2015 - 04/2004
2Immunoglobulins (Immunoglobulin)IBA
01/2015 - 01/2004
2C-Reactive ProteinIBA
01/2014 - 05/2012
2Interleukin-6 (Interleukin 6)IBA
01/2014 - 05/2012
2Lipid AIBA
05/2012 - 07/2005
2Filgrastim (Neupogen)FDA Link
07/2010 - 09/2007
2tigecycline (Tygacil)FDA Link
01/2010 - 03/2007
2Methicillin (Metin)FDA Link
01/2010 - 09/2004
2DaptomycinFDA Link
01/2010 - 03/2007
2emtricitabine (Emtriva)FDA Link
09/2009 - 04/2008
2lamivudine drug combination abacavirFDA Link
09/2009 - 04/2008
2atazanavir (Reyataz)FDA Link
09/2009 - 07/2007
2abacavir (Ziagen)FDA Link
10/2008 - 04/2008
2Lamivudine (3TC)FDA Link
02/2008 - 12/2004
2Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)FDA LinkGeneric
02/2008 - 12/2004
2Reverse Transcriptase InhibitorsIBA
07/2007 - 02/2005
2quinupristin-dalfopristin (Synercid)FDA Link
03/2007 - 12/2005
2GlycopeptidesIBA
03/2007 - 04/2006
2Rifampin (Rifampicin)FDA LinkGeneric
09/2006 - 01/2005
2Oxazolidinones (2 Oxazolidone)IBA
04/2006 - 09/2004
2Amphotericin B (Amphotericin)FDA LinkGeneric
04/2006 - 03/2004
2Fluconazole (Zonal)FDA LinkGeneric
04/2006 - 01/2006
2StreptograminsIBA
04/2006 - 09/2004
2Fibric Acids (Fibrates)IBA
02/2006 - 01/2006
2Penicillins (Penicillin)FDA Link
12/2005 - 12/2002
2Methadone (Dolophine)FDA LinkGeneric
11/2005 - 04/2004
2Anti-Bacterial Agents (Antibiotics)IBA
06/2005 - 03/2002
2AntibodiesIBA
12/2004 - 04/2003
2Ampicillin (Omnipen)FDA LinkGeneric
07/2003 - 12/2002
1carbapenemaseIBA
09/2015
1darunavir (Prezista)FDA Link
09/2015

Therapy/Procedure

33Highly Active Antiretroviral Therapy (HAART)
08/2015 - 01/2002
5Drug Therapy (Chemotherapy)
12/2014 - 11/2005
3Intensive Care (Surgical Intensive Care)
01/2014 - 06/2002
2Polypharmacy
03/2015 - 12/2014
2Intravesical Administration
12/2010 - 10/2009
2Aftercare (After-Treatment)
12/2007 - 04/2006
2Oral Administration
09/2006 - 01/2005